These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 7116299

  • 1. Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experience.
    Cornwell GG, Pajak TF, Kochwa S, McIntyre OR, Glowienka LP, Brunner K, Rafla S, Silver RT, Cooper MR, Henderson E, Kyle RA, Haurani FI, Cuttner J.
    Cancer; 1982 Nov 01; 50(9):1669-75. PubMed ID: 7116299
    [Abstract] [Full Text] [Related]

  • 2. Vincristine and prednisone prolong the survival of patients receiving intravenous or oral melphalan for multiple myeloma: Cancer and Leukemia Group B experience.
    Cornwell GG, Pajak TF, Kochwa S, McIntyre OR, Glowienka LP, Brunner K, Rafla S, Coleman M, Cooper MR, Henderson E.
    J Clin Oncol; 1988 Sep 01; 6(9):1481-90. PubMed ID: 3047338
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vincristine, BCNU, doxorubicin, and prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group study.
    Bonnet J, Alexanian R, Salmon S, Bottomley R, Amare M, Haut A, Dixon D.
    Cancer Treat Rep; 1982 Jun 01; 66(6):1267-71. PubMed ID: 7044534
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Phase III study of intermittent carmustine (BCNU), cyclophosphamide, and prednisone versus intermittent melphalan and prednisone in myeloma.
    Abramson N, Lurie P, Mietlowski WL, Schilling A, Bennett JM, Horton J.
    Cancer Treat Rep; 1982 Jun 01; 66(6):1273-7. PubMed ID: 7044535
    [Abstract] [Full Text] [Related]

  • 10. Melphalan and prednisone (MP) versus vincristine, BCNU, adriamycin, melphalan and dexamethasone (VBAMDex) therapy for multiple myeloma. Early results of a multicenter trial. The German Myeloma Treatment Group.
    Peest D, Deicher H, Coldewey R, von Broen IM, Cammerer U, Hein R, Hoffmann L, Konyar H, Kreuser ED, Selbach J.
    Onkologie; 1990 Feb 01; 13(1):43-4. PubMed ID: 2186324
    [Abstract] [Full Text] [Related]

  • 11. A randomized trial of melphalan and prednisone versus melphalan, prednisone, cyclophosphamide, MeCCNU, and vincristine in untreated multiple myeloma.
    Pavlovsky S, Saslavsky J, Tezanos Pinto M, Palmer L, Curuchet M, Lein JM, Garay G, Dragosky M, Quiroga-Micheo E, Huberman AB.
    J Clin Oncol; 1984 Jul 01; 2(7):836-40. PubMed ID: 6376722
    [Abstract] [Full Text] [Related]

  • 12. Nitrosoureas in multiple myeloma.
    Salmon SE.
    Cancer Treat Rep; 1976 Jun 01; 60(6):789-94. PubMed ID: 782701
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of two combination chemotherapy regimens for multiple myeloma: methyl-CCNU, cyclophosphamide, and prednisone versus melphalan and prednisone.
    Cavagnaro F, Lein JM, Pavlovsky S, Becherini JO, Pileggi JE, Micheo EQ, Jait C, Musso A, Suárez A, Pizzolato M.
    Cancer Treat Rep; 1980 Jan 01; 64(1):73-9. PubMed ID: 6991106
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness of two-stage treatment of multiple myeloma with melphalan and with melphalan in combination with cyclophosphamide, carmustine, vincristine and prednisone.
    Snigurowicz J, Kraj M, Rostkowska J, Maj S, Mariańska B, Mendek E, Roszkowski S, Kilian Z, Kołakowski L.
    Arch Immunol Ther Exp (Warsz); 1981 Jan 01; 29(2):145-53. PubMed ID: 7030265
    [No Abstract] [Full Text] [Related]

  • 19. [Combination chemotherapy with vincristine, melphalan, CCNA, cyclophosphamide, prednisone in myeloma].
    Le Loët X, Monconduit M, Menard JF, Deshayes P, Grobois B, Tanguy A, Prevost E, Piguet H.
    Rev Rhum Mal Osteoartic; 1984 May 01; 51(5):263-7. PubMed ID: 6740189
    [Abstract] [Full Text] [Related]

  • 20. Complete remission induction with combined VBMCP chemotherapy and interferon (rIFN alpha 2b) in patients with multiple myeloma.
    Oken MM, Kyle RA, Greipp PR, Kay NE, Tsiatis A, Gregory SA, Spiegel R J, O'Connell M J.
    Leuk Lymphoma; 1996 Feb 01; 20(5-6):447-52. PubMed ID: 8833401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.